1
|
Marcé D, Canu D, Laurent C, Pottier C, Jullie ML, Kervarrec T, Beylot-Barry M, Samimi M. Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases. Ann Dermatol Venereol 2023; 150:294-296. [PMID: 37442745 DOI: 10.1016/j.annder.2023.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 12/30/2022] [Accepted: 04/11/2023] [Indexed: 07/15/2023]
Affiliation(s)
- D Marcé
- Dermatology Department, University Hospital of Tours, 37000 Tours, France
| | - D Canu
- Dermatology Department, University Hospital of Bordeaux, 33000 Bordeaux, France
| | - C Laurent
- Dermatology Department, University Hospital of Rennes, 35000 Rennes, France
| | - C Pottier
- Dermatology Department, University Hospital of Tours, 37000 Tours, France
| | - M-L Jullie
- Pathology Department, University Hospital of Bordeaux, 33000 Bordeaux, France
| | - T Kervarrec
- Pathology Department, University Hospital of Tours, 37000 Tours, France
| | - M Beylot-Barry
- Dermatology Department, University Hospital of Bordeaux, 33000 Bordeaux, France; Univ. Bordeaux, UMR 1312 INSERM, 33000 Bordeaux, France
| | - M Samimi
- Dermatology Department, University Hospital of Tours, 37000 Tours, France.
| |
Collapse
|
2
|
Alsomali DY, Bakshi N, Kharfan-Dabaja M, El Fakih R, Aljurf M. Diagnosis and Treatment of Subcutaneous Panniculitis-like T-cell Lymphoma: A Systematic Literature Review. Hematol Oncol Stem Cell Ther 2023; 16:110-116. [PMID: 34015273 DOI: 10.1016/j.hemonc.2021.04.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 03/24/2021] [Accepted: 04/25/2021] [Indexed: 01/31/2023] Open
Abstract
OBJECTIVES The aim of this systematic review is to investigate different diagnostic methods and the available treatment options for subcutaneous panniculitis-like T-cell lymphoma (SPTCL). METHODS We searched PubMed, Web of Science, SCOPUS, EBSCO, and CINAHL Plus for published case reports of SPTCL. From each record, we extracted data of the diagnostic methods, immunohistochemical profile, clinical characteristics, and the treatment approaches provided. Data were summarized and narratively synthesized to highlight the various diagnostic methods and treatment options of SPTCL. RESULTS Our literature search yielded 1293 unique citations. Following screening, nine articles reporting a total of 15 cases were included in this systematic review. All patients presented with subcutaneous nodules. Three of the 15 cases were initially misdiagnosed. The atypical lymphoid cells were positive for CD2, CD3, granzyme B, and TIA-1 and negative for CD1a, EBER, and CD20 in all the reported cases. The atypical lymphoid cells were positive for CD45RO in four out of seven cases, positive for CD56 in three out of 12 cases tested, while positive for CD5 and CD8 in the majority of cases. Therapy ranged from topical agents to immunosuppressive agents all the way to multiagent chemotherapy. CONCLUSION SPTCL is a rare lymphoma. Diagnosis is highly dependent on the immunohistochemical stains added to histopathologic and radiologic findings. Therapy is dependent on the pace of the disease, with encouraging results obtained with single-agent cyclosporine.
Collapse
Affiliation(s)
| | - Nasir Bakshi
- King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| | | | - Riad El Fakih
- King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| | - Mahmoud Aljurf
- King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| |
Collapse
|
3
|
Zhao Y, Maule J, Li Y, Neff J, McCall CM, Hao T, Yang W, Rehder C, Yang LH, Wang E. Sequential development of human herpes virus 8-positive diffuse large B-cell lymphoma and chronic myelomonocytic leukemia in a 59 year old female patient with hemoglobin SC disease. Pathol Res Pract 2019; 215:152704. [PMID: 31699472 DOI: 10.1016/j.prp.2019.152704] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Revised: 10/18/2019] [Accepted: 10/19/2019] [Indexed: 12/01/2022]
Abstract
Hematolymphoid neoplasms, including lymphoma and myeloid neoplasms, can occur in patients with sickle cell disease (SCD) or equivalent hemoglobinopathy, but an underlying connection between the two conditions has yet to be fully determined. Herein, we report a unique case of sequential development of two separate hematolymphoid neoplasms, human herpes virus 8 (HHV8)-positive diffuse large B-cell lymphoma (DLBCL) and chronic myelomonocytic leukemia, in a 59 year-old African American female with hemoglobin SC disease. While etiology of immunodeficiency is unknown, the potential causes include hydroxyurea therapy, disease related immunomodulation, chronic inflammation, and relatively old age. The leukemia cells demonstrated profound trilineage dysplasia and harbored complex cytogenetic abnormalities with loss of chromosome 5q and 7q, which are often observed in therapy-related myeloid neoplasms. Besides the potential causes listed above, we propose that myeloid leukemia in this setting may result from genomic changes due to excessive hematopoietic replication triggered by a hemolysis-induced cytokine storm. While myeloid neoplasms in the setting of SCD seems to herald a dismal clinical outcome per the literature, the HHV8-positive DLBCL in our case was apparently indolent, opposing the current perception of its clinical outcome.
Collapse
Affiliation(s)
- Yue Zhao
- Department of Pathology, First affiliated Hospital and College of Basic Medical Science of China Medical University, Shenyang, 110122 PR China; Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710
| | - Jake Maule
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710
| | - Yang Li
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710; Division of Hematology/Oncology, Department of Medicine, Shengjing Hospital affiliated to China Medical University, Shenyang, 110004, PR China
| | - Jadee Neff
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710
| | - Chad M McCall
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710
| | - Tie Hao
- Department of Clinical Laboratory, Anshan Central Hospital, Anshan, Liaoning, 114001 PR China
| | - Weihong Yang
- Department of Clinical Laboratory, Anshan Central Hospital, Anshan, Liaoning, 114001 PR China
| | - Catherine Rehder
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710
| | - Lian-He Yang
- Department of Pathology, First affiliated Hospital and College of Basic Medical Science of China Medical University, Shenyang, 110122 PR China; Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710
| | - Endi Wang
- Department of Pathology, Duke University School of Medicine, Durham, NC, USA, 27710.
| |
Collapse
|